OTC · GNRS
The Greenrose Holding Company Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Down-$0.00 (-50.00%)
Updated Sep 19, 2026, 3:05 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.77K
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 101.98K
- Avg. volume
- 1.62K
Price performance
GNRS price history
1M range · 0 trading sessions · Daily adjusted prices
GNRS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest GNRS news
The latest Smart Investors Daily articles mentioning GNRS.
Stock researchCompany · Overview
GNRS research
Overview
Company profile and research snapshot.
Company profile
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
